Back to Search
PHILLIP TRUONG, PHARM.D
PHARM.D
Pharmacist
NPI: 1447583968Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
18073(NC)
Research & Publications (20)
Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
PMID 18676091·Int J Radiat Oncol Biol Phys·2009
8-other
The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer.
PMID 18595686·Eur J Cancer·2008
8-other
Reliability and validity testing of the Patient and Observer Scar Assessment Scale in evaluating linear scars after breast cancer surgery.
PMID 17230080·Plast Reconstr Surg·2007
4-observational
The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center.
PMID 17321065·Int J Radiat Oncol Biol Phys·2007
4-observational
Optimizing locoregional control and survival for women with breast cancer: a review of current developments in postmastectomy radiotherapy.
PMID 16445373·Expert Rev Anticancer Ther·2006
6-review
Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer.
PMID 16720143·Am J Surg·2006
4-observational
Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy.
PMID 16813705·Can J Urol·2006
8-other
The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
PMID 15812825·Cancer·2005
8-other
Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
PMID 15817335·Int J Radiat Oncol Biol Phys·2005
8-other
Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy.
PMID 15850919·Int J Radiat Oncol Biol Phys·2005
8-other
Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
PMID 15922205·J Am Coll Surg·2005
4-observational
Locoregional recurrence risks in elderly breast cancer patients treated with mastectomy without adjuvant radiotherapy.
PMID 15939262·Eur J Cancer·2005
4-observational
Standardized assessment of breast cancer surgical scars integrating the Vancouver Scar Scale, Short-Form McGill Pain Questionnaire, and patients' perspectives.
PMID 16217470·Plast Reconstr Surg·2005
8-other
The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer.
PMID 15803010·Am J Clin Oncol·2005
8-other
Short communication: Setup variations in locoregional radiotherapy for breast cancer: an electronic portal imaging study.
PMID 16046427·Br J Radiol·2005
8-other
Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.
PMID 15078851·CMAJ·2004
6-review
A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
PMID 14967436·Int J Radiat Oncol Biol Phys·2004
8-other
Adjuvant radiation therapy after breast-conserving surgery in elderly women with early-stage breast cancer: controversy or consensus?
PMID 15023241·Clin Breast Cancer·2004
6-review
Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer.
PMID 12377331·Int J Radiat Oncol Biol Phys·2002
8-other
Is biochemical response more important than duration of neoadjuvant hormone therapy before radiotherapy for clinically localized prostate cancer? An analysis of the 3- versus 8-month randomized trial.
PMID 19395187·Int J Radiat Oncol Biol Phys·2010
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5040 BEATTIES FORD RD
CHARLOTTE, NC 28216 - Phone
- (704) 394-1714
Quick Facts
- NPI
- 1447583968
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile